GlyTech
GlyTech, Inc. | World-leading glycotechnology
- Business Model
- B2B
- Website
- glytech-inc.com
- Total Funding
- $6.3M
- Last Round
- $6.3M Series AMay 2018
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
GlyTech develops medicines using glycan production and chemical glycosylation technologies, and provides glycosylated-compound synthesis and analysis services.
Summary
GlyTech is a Biotech company. It has raised $6.3M in total across 1 round, most recently a $6.3M Series A round in May 2018. Investors include SBI Investment.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2018
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/glytech"><img src="https://indexed.vc/api/badge/company/glytech" alt="GlyTech on Indexed.vc" width="260" height="76" /></a>